What does Valbenazine (Ingrezza, Ingrezza Sprinkle) do in plain English—and how does it work inside your body?
Valbenazine is an FDA-regulated Vesicular Monoamine Transporter 2 Inhibitor (RxNorm RxCUI RXN-703701080-2585). Mechanistically, Clinical mechanism for Valbenazine (80 mg/1 Capsule and 40 mg/1 Capsule, manufactured/labeled by Neurocrine Biosciences, Inc.) centers on vesicular monoamine transporter 2 inhibitor target modulation following oral-route uptake, maintaining therapeutic plasma exposure across FDA-listed 70370-1080, 70370-4040 regimens. [1][2].
When your doctor writes a prescription for Valbenazine (RxNorm RxCUI RXN-703701080-2585, also dispensed under brand names including Ingrezza, Ingrezza Sprinkle), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, Clinical mechanism for Valbenazine (80 mg/1 Capsule and 40 mg/1 Capsule, manufactured/labeled by Neurocrine Biosciences, Inc.) centers on vesicular monoamine transporter 2 inhibitor target modulation following oral-route uptake, maintaining therapeutic plasma exposure across FDA-listed 70370-1080, 70370-4040 regimens. [2].
Across real-world patient logs on dotMD (79% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Valbenazine tablet bottle and confirm with your pharmacist that it matches your prescribed strength (80 mg/1 Capsule, 40 mg/1 Capsule, 60 mg/1 Capsule, Kit).